Monocyte chemotactic protein-1 in the vitreous of patients with proliferative diabetic retinopathy

被引:87
作者
Mitamura, Y
Takeuchi, S
Matsuda, A
Tagawa, Y
Mizue, Y
Nishihira, J
机构
[1] Toho Univ, Sakura Hosp, Dept Ophthalmol, Chiba 2858741, Japan
[2] Hokkaido Univ, Sch Med, Dept Ophthalmol, Sapporo, Hokkaido 060, Japan
[3] Hokkaido Univ, Sch Med, Cent Res Inst, Sapporo, Hokkaido 060, Japan
[4] Sapporo Immunodiagnost Lab, Sapporo, Hokkaido, Japan
关键词
monocyte chemotactic protein-1; proliferative diabetic retinopathy; vitreous; proliferative membrane; retinal photocoagulation;
D O I
10.1159/000050900
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To investigate the correlation between monocyte chemotactic protein-1 (MCP-1) levels in the vitreous and clinical findings in eyes with proliferative diabetic retinopathy (PDR). Methods: We assayed MCP-1 levels by ELISA in vitreous samples of 88 consecutive patients with PDR (52 eyes) and macular holes or idiopathic epimacular membrane (controls, 36 eyes). Results:The level of MCP-1 in the vitreous was 2,097.5 +/- 1,099.4 pg/ml (mean SD) in PDR, and 504.3 +/- 405.6 pg/ml in the controls. In PDR eyes, multivariate regression analysis revealed a significant association between MCP-1 levels in the vitreous and the degree of proliferative membrane, and a significant negative association between MCP-1 levels and the extent of preoperative retinal photocoagulation. Conclusion: The results suggest that MCP-1 may play a role in the development of the proliferative phase of PDR. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:415 / 418
页数:4
相关论文
共 12 条
[1]   Monocyte chemotactic protein-1 in proliferative vitreoretinal disorders [J].
AbuElAsrar, AM ;
VanDamme, J ;
Put, W ;
Veckeneer, M ;
Dralands, L ;
Billiau, A ;
Missotten, L .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1997, 123 (05) :599-606
[2]   INCREASED VASCULAR ENDOTHELIAL GROWTH-FACTOR LEVELS IN THE VITREOUS OF EYES WITH PROLIFERATIVE DIABETIC-RETINOPATHY [J].
ADAMIS, AP ;
MILLER, JW ;
BERNAL, MT ;
DAMICO, DJ ;
FOLKMAN, J ;
YEO, TK ;
YEO, KT .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1994, 118 (04) :445-450
[3]   CLASS-II ANTIGEN EXPRESSION IN DIABETIC PRERETINAL MEMBRANES [J].
BAUDOUIN, C ;
GORDON, WC ;
FREDJREYGROBELLET, D ;
BAUDOUIN, F ;
PEYMAN, G ;
GASTAUD, P ;
BAZAN, NG .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1990, 109 (01) :70-74
[4]  
Capeans C, 1998, RETINA-J RET VIT DIS, V18, P546
[5]   CYTOKINES IN PROLIFERATIVE DIABETIC-RETINOPATHY AND PROLIFERATIVE VITREORETINOPATHY [J].
ELNER, SG ;
ELNER, VM ;
JAFFE, GJ ;
STUART, A ;
KUNKEL, SL ;
STRIETER, RM .
CURRENT EYE RESEARCH, 1995, 14 (11) :1045-1053
[6]   MACROPHAGES IN PROLIFERATIVE VITREORETINOPATHY AND PROLIFERATIVE DIABETIC-RETINOPATHY - DIFFERENTIATION OF SUBPOPULATIONS [J].
ESSER, P ;
HEIMANN, K ;
WIEDEMANN, P .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1993, 77 (11) :731-733
[7]   CHEMOTACTIC CYTOKINE (IL-8 AND MCP-1) GENE-EXPRESSION BY HUMAN WHOLE-BLOOD [J].
HAM, JM ;
KUNKEL, SL ;
DIBB, CR ;
STANDIFORD, TJ ;
ROLFE, MW ;
STRIETER, RM .
IMMUNOLOGICAL INVESTIGATIONS, 1991, 20 (04) :387-394
[8]   Transforming growth factor β2 in the vitreous in proliferative diabetic retinopathy [J].
Hirase, K ;
Ikeda, T ;
Sotozono, C ;
Nishida, K ;
Sawa, H ;
Kinoshita, S .
ARCHIVES OF OPHTHALMOLOGY, 1998, 116 (06) :738-741
[9]   PURIFICATION AND CHARACTERIZATION OF A NOVEL MONOCYTE CHEMOTACTIC AND ACTIVATING FACTOR PRODUCED BY A HUMAN MYELOMONOCYTIC CELL-LINE [J].
MATSUSHIMA, K ;
LARSEN, CG ;
DUBOIS, GC ;
OPPENHEIM, JJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (04) :1485-1490
[10]  
ROLLINS BJ, 1991, BLOOD, V78, P1112